gabapentin NDC 71610-069

NDC codes

FDA NDC Directory

Product NDC (as listed)71610-069Labeler and product segments. Claims need a package NDC.

Product NDC at billing width71610-0069Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
71610-069-45	71610006945	45 TABLET, FILM COATED in 1 BOTTLE (71610-069-45)Marketed from Feb 26, 2021
71610-069-60	71610006960	90 TABLET, FILM COATED in 1 BOTTLE (71610-069-60)Marketed from May 15, 2018
71610-069-80	71610006980	180 TABLET, FILM COATED in 1 BOTTLE (71610-069-80)Marketed from May 15, 2018
71610-069-92	71610006992	270 TABLET, FILM COATED in 1 BOTTLE (71610-069-92)Marketed from May 15, 2018

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): gabapentin
Generic name (nonproprietary): gabapentin
Active ingredients: Gabapentin — 600 mg/1
Dosage form: Tablet, Film coated
Route: Oral
Labeler: Aphena Pharma Solutions - Tennessee, LLC
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 077525
Marketing start: Aug 24, 2006
Listing expires: Dec 31, 2026
Other FDA classes: Decreased Central Nervous System Disorganized Electrical Activity (Physiologic effect)
Identifiers: Product ID 71610-069_cef6341b-bae4-4e08-a609-1afef9307f2eSPL ID cef6341b-bae4-4e08-a609-1afef9307f2eSPL set ID 7790d906-af26-4e60-bc6f-e906ec03cc24RxCUI 310433UNII 6CW7F3G59X
Pharmacologic class: Anti-epileptic Agent

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N471610006945 followed by a unit qualifier and the quantity

Package 71610-0069-45. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Mar 21, 2022.

Indications (excerpt from the label)

Gabapentin is indicated for: Management of postherpetic neuralgia in adults Adjunctive therapy in the treatment of partial onset seizures, with and without secondary generalization, in adults and pediatric patients 3 years and older with epilepsy Gabapentin is indicated for: Postherpetic neuralgia in adults ( 1 ) Adjunctive therapy in the treatment of partial onset seizures, with and without secondary generalization, in adults and pediatric patients 3 years and older with epilepsy ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 077525

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 077525
Product	Strength	Form · route	Labeler	Product NDC
gabapentin	Gabapentin 800 mg/1	Tablet, Film coatedOral	Sun Pharmaceutical Industries, Inc.	62756-204
gabapentin	Gabapentin 600 mg/1	Tablet, Film coatedOral	Sun Pharmaceutical Industries, Inc.	62756-202